4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001415889-24-028466
INTERIM CEO gave up 68,343 shares (to pay taxes)
- INTERIM CEO acquired 118,840 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Walker Neal INTERIM CEO | 2024-12-04 | Option exercise | +118,840 | $1.52 | $180,637 | 1,501,973 | D |
| Walker Neal INTERIM CEO | 2024-12-04 | Shares withheld for taxes | −68,343 | $3.76 | $256,970 | 1,433,630 | D |
| Derivatives | |||||||
| Walker Neal INTERIM CEO | 2024-12-04 | Option exercise · Employee Stock Option (right to buy) | −118,840 | 0 | D | ||
Loading xslF345X05/form4-12062024_041206.xml…